# Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Lung Cancer

> **NCT00603057** · — · COMPLETED · sponsor: **University of Michigan Rogel Cancer Center** · enrollment: 115 (actual)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00603057
- **Lead sponsor:** University of Michigan Rogel Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2013-09
- **Final completion:** 2015-03
- **Target enrollment:** 115 (ACTUAL)
- **Last updated:** 2019-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00603057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00603057, "Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Lung Cancer". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT00603057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*